Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Long Term Excess Mortality of Acute Myocardial Infarction in Patients With and Without Diabetes: A Population-based Cohort Study

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT02591576
Recruitment Status : Completed
First Posted : October 29, 2015
Last Update Posted : October 29, 2015
Sponsor:
Information provided by (Responsible Party):
Oras Alabas, University of Leeds

Brief Summary:
Diabetes is key risk factor for death following acute myocardial infarction. However, the long-term excess risk of death associated with diabetes following acute myocardial infarction not known. Investigators aimed to determine the long-term excess risk of death associated with diabetes among patients with ST-elevation myocardial infarction (STEMI) and non-STEMI (NSTEMI) after adjustment for multimorbidity, risk factors and cardiac treatments.

Condition or disease
Effect of Diabetes on Long Term Excess Mortality Following Acute Myocardial Infarction

Layout table for study information
Study Type : Observational
Actual Enrollment : 700000 participants
Observational Model: Cohort
Time Perspective: Retrospective
Study Start Date : January 2003
Actual Primary Completion Date : July 2013

Resource links provided by the National Library of Medicine

MedlinePlus related topics: Heart Attack

Group/Cohort
ST-elevation myocardial infarction (STEMI)
non-ST-elevation myocardial infarction (NSTEMI)



Primary Outcome Measures :
  1. Long term excess mortality [ Time Frame: 8 years ]


Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   18 Years to 100 Years   (Adult, Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population
STEMI and NSTEMI were eligible for analysis if they have been hospitalised following AMI between the period of 2003-2013 and were aged at least 18 years. Only records of the first admission were considered for analyses.
Criteria

Inclusion Criteria:

  • Acute myocardial infarction
  • Both sex
  • 18 years

Exclusion Criteria:


Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):
Layout table for additonal information
Responsible Party: Oras Alabas, Dr, University of Leeds
ClinicalTrials.gov Identifier: NCT02591576     History of Changes
Other Study ID Numbers: NIGB: ECC 1-06 (d)/2011
First Posted: October 29, 2015    Key Record Dates
Last Update Posted: October 29, 2015
Last Verified: October 2015
Keywords provided by Oras Alabas, University of Leeds:
Diabetes
ST-elevation myocardial infarction (STEMI)
non-STEMI
Excess mortality
Relative survival
Additional relevant MeSH terms:
Layout table for MeSH terms
Myocardial Infarction
Infarction
Ischemia
Pathologic Processes
Necrosis
Myocardial Ischemia
Heart Diseases
Cardiovascular Diseases
Vascular Diseases